BenevolentAI SA
BenevolentAI S.A. operates as a clinical-stage artificial intelligence (AI) enabled drug discovery and development company. Its Benevolent platform integrates AI and science to uncover and develop drugs for complex diseases. The company's development pipeline includes BEN-8744, an oral phosphodiesterase 10 (PDE10) inhibitor under phase 1 study for the treatment of Ulcerative Colitis; BEN-28010, a… Read more
BenevolentAI SA (BAI) - Total Assets
Latest total assets as of December 2023: €123.83 Million EUR
Based on the latest financial reports, BenevolentAI SA (BAI) holds total assets worth €123.83 Million EUR as of December 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BenevolentAI SA - Total Assets Trend (2018–2023)
This chart illustrates how BenevolentAI SA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BenevolentAI SA - Asset Composition Analysis
Current Asset Composition (December 2023)
BenevolentAI SA's total assets of €123.83 Million consist of 73.8% current assets and 26.2% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 29.5% |
| Accounts Receivable | €0.00 | 0.0% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €19.00K | 0.0% |
| Goodwill | €23.48 Million | 19.0% |
Asset Composition Trend (2018–2023)
This chart illustrates how BenevolentAI SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BenevolentAI SA's current assets represent 73.8% of total assets in 2023, an increase from 51.9% in 2018.
- Cash Position: Cash and equivalents constituted 29.5% of total assets in 2023, down from 36.2% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 18.0% of total assets, a decrease from 38.0% in 2018.
- Asset Diversification: The largest asset category is goodwill at 19.0% of total assets.
BenevolentAI SA Competitors by Total Assets
Key competitors of BenevolentAI SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
BenevolentAI SA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - BenevolentAI SA generates 0.06x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - BenevolentAI SA is currently not profitable relative to its asset base.
BenevolentAI SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.65 | 5.93 | 2.54 |
| Quick Ratio | 3.65 | 5.93 | 2.54 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €66.35 Million | € 126.45 Million | € 34.32 Million |
BenevolentAI SA - Advanced Valuation Insights
This section examines the relationship between BenevolentAI SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.11 |
| Latest Market Cap to Assets Ratio | 0.08 |
| Asset Growth Rate (YoY) | -33.4% |
| Total Assets | €123.83 Million |
| Market Capitalization | $9.51 Million USD |
Valuation Analysis
Below Book Valuation: The market values BenevolentAI SA's assets below their book value (0.08 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: BenevolentAI SA's assets decreased by 33.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for BenevolentAI SA (2018–2023)
The table below shows the annual total assets of BenevolentAI SA from 2018 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €123.83 Million | -33.41% |
| 2022-12-31 | €185.95 Million | +100.63% |
| 2021-12-31 | €92.68 Million | -37.42% |
| 2020-12-31 | €148.10 Million | -2.26% |
| 2019-12-31 | €151.53 Million | +68.51% |
| 2018-12-31 | €89.92 Million | -- |